Want to see AU:C79 full AI Analyst Report?
C79 Stock Chart & Stats
AU$5.52
AU$0.09(1.63%)
At close: 4:00 PM EDT
AU$5.52
AU$0.09(1.63%)
Day’s Range― - ―
52-Week RangeAU$4.93 - AU$10.13
Previous CloseN/A
Volume106.70K
Average Volume (3M)347.84K
Market Cap
AU$669.94M
Enterprise ValueAU$899.09
Total Cash (Recent Filing)AU$21.57M
Total Debt (Recent Filing)AU$55.10M
Price to Earnings (P/E)―
Beta1.70
Next Earnings
Aug 11, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding116,511,300
10 Day Avg. Volume301,690
30 Day Avg. Volume347,840
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)2.73
Price to Sales (P/S)8.20
P/FCF Ratio-9.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$8.90Price Target Upside61.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.07
Revenue Forecast (FY)AU$114.45M
Bulls Say, Bears Say
Bulls Say
High Gross MarginA near-100% gross margin indicates Chrysos’s PhotonAssay technology has very low direct costs versus pricing, implying strong unit economics and pricing power. Over 2-6 months this structural margin buffer can fund R&D and commercial scale-up once fixed operating costs are absorbed.
Low LeverageA low debt-to-equity ratio signals a conservative capital structure and financial flexibility. This durable strength reduces default and refinancing risk, allowing the company to invest in deployments, service capacity and R&D without immediate pressure from interest or covenant constraints.
Usage-based Recurring RevenueA fee-per-use and services model creates recurring, utilization-linked revenue as installed units grow. Over months this drives predictable revenue expansion with an installed-base flywheel: more units and higher utilization generate sustainable service income and improve lifetime customer value.
Bears Say
Negative ProfitabilityPersistent negative net and declining EBIT margins show the business has not yet converted high gross margins to bottom-line profit. Structurally, this limits retained earnings, constrains reinvestment and increases dependence on external funding until scale or cost structure improvements are realized.
Weak Cash GenerationNegative free cash flow and poor operating cash conversion indicate earnings are not translating into spendable cash. Over a multi-month horizon this weakens the company’s ability to self-fund deployments and working capital, elevating execution risk and potential dilution if financing is needed.
Earnings VolatilityExtremely large negative EPS growth points to volatile and deteriorating earnings quality. This structural volatility undermines forecasting, raises business risk for customers and investors, and complicates strategic planning and capacity investment until profitability stabilizes.
Chrysos Corp. Ltd. News
C79 FAQ
What was Chrysos Corp. Ltd.’s price range in the past 12 months?
Chrysos Corp. Ltd. lowest share price was AU$4.93 and its highest was AU$10.13 in the past 12 months.
What is Chrysos Corp. Ltd.’s market cap?
Chrysos Corp. Ltd.’s market cap is AU$669.94M.
When is Chrysos Corp. Ltd.’s upcoming earnings report date?
Chrysos Corp. Ltd.’s upcoming earnings report date is Aug 11, 2026 which is in 10 days.
How were Chrysos Corp. Ltd.’s earnings last quarter?
Chrysos Corp. Ltd. released its earnings results on Feb 17, 2026. The company reported AU$0.006 earnings per share for the quarter, beating the consensus estimate of AU$0 by AU$0.006.
Is Chrysos Corp. Ltd. overvalued?
According to Wall Street analysts Chrysos Corp. Ltd.’s price is currently Undervalued.
Does Chrysos Corp. Ltd. pay dividends?
Chrysos Corp. Ltd. does not currently pay dividends.
What is Chrysos Corp. Ltd.’s EPS estimate?
Chrysos Corp. Ltd.’s EPS estimate is <0.01.
How many shares outstanding does Chrysos Corp. Ltd. have?
Chrysos Corp. Ltd. has 116,511,300 shares outstanding.
What happened to Chrysos Corp. Ltd.’s price movement after its last earnings report?
Chrysos Corp. Ltd. reported an EPS of AU$0.006 in its last earnings report, beating expectations of AU$0. Following the earnings report the stock price went up 2.987%.
Which hedge fund is a major shareholder of Chrysos Corp. Ltd.?
Currently, no hedge funds are holding shares in AU:C79
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chrysos Corp. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$8.90 (61.23% Upside)
AU$8.90 (61.23% Upside)
Insider Transactions
Sold Shares
Worth AU$2.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
16.34%
Trailing 12-Months
Company Description
Chrysos Corp. Ltd.
Chrysos Corporation Limited is dedicated to creating and delivering advanced solutions for the mining industry. Established in 2016 and based in Adelaide, Australia, the company's flagship product is PhotonAssay. This innovative technology enables the accurate and efficient analysis of elements such as gold, silver, and copper, among others.
C79 Stock 12 Month Forecast
Average Price Target
AU$8.90
▲(61.23% Upside)
Technical Analysis
Pointerra
―
Aerometrex Ltd.
―
Vection Technologies Ltd.
―
UUV Aquabotix Ltd.
―
Nuix Ltd.
―